The expression of CTLA-4 (11.96 ± 0.61 versus 15.74 ± 0.77, p < 0.01) was significantly elevated on Tregs of COPD patients (Fig. 2D), indicating a heightened suppressive function of Tregs in COPD. Here, CTLA4 is linked to chronic obstructive pulmonary disease.